Skip to main content
Erschienen in: Reproductive Medicine and Biology 1/2012

01.01.2012 | Original Article

Alternative strategies to in vitro fertilization/intracytoplasmic sperm injection treatment for aged infertile women

verfasst von: Wataru Isono, Osamu Wada-Hiraike, Akira Shirane, Akihisa Fujimoto, Yutaka Osuga, Tetsu Yano, Yuji Taketani

Erschienen in: Reproductive Medicine and Biology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to maximize the chance of pregnancy and provide an optimal protocol for infertile female patients of advanced reproductive age as an alternative to in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) treatment.

Methods

We retrospectively analyzed medical records of 432 infertile women aged ≥38 at the beginning of the treatment. Stepwise non-IVF/ICSI treatments using timed intercourse or intrauterine insemination, with or without controlled ovarian stimulation, were adopted for all patients. In this population, we extracted 8 representative infertility factors and examined these effects on fertility rate by calculating clinical pregnancy rate.

Results

The prognosis for infertile women possessing at least one of the three factors, ‘advanced female age (≥42 years)’, ‘endometriosis/adenomyosis’, and ‘tubal infertility’ was apparently poor because only 5 out of 155 women were able to conceive (1.02% per cycle). In contrast, 95 patients without the four factors, ‘advanced female age’, ‘endometriosis/adenomyosis’, ‘tubal infertility’, and ‘male infertility’, were more likely to conceive (9.14% per cycle).

Conclusions

Fertility centers can offer appropriate protocols for non-IVF/ICSI treatment and establish guidelines for aged infertile patients by examining infertility factors and considering their combinations.
Literatur
1.
Zurück zum Zitat Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, Grunfeld L. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet. 1991;337:1375–7.PubMedCrossRef Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, Grunfeld L. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet. 1991;337:1375–7.PubMedCrossRef
2.
Zurück zum Zitat Ziebe S, Devroey P. Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update. 2008;14:583–92.PubMedCrossRef Ziebe S, Devroey P. Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. Hum Reprod Update. 2008;14:583–92.PubMedCrossRef
3.
Zurück zum Zitat Tsafrir A, Simon A, Margalioth EJ, Laufer N. What should be the first-line treatment for unexplained infertility in women over 40 years of age—ovulation induction and IUI, or IVF? Reprod Biomed Online. 2009;19(Suppl 4):4334.PubMed Tsafrir A, Simon A, Margalioth EJ, Laufer N. What should be the first-line treatment for unexplained infertility in women over 40 years of age—ovulation induction and IUI, or IVF? Reprod Biomed Online. 2009;19(Suppl 4):4334.PubMed
4.
Zurück zum Zitat Brandes M, van der Steen JO, Bokdam SB, Hamilton CJ, de Bruin JP, Nelen WL, Kremer JA. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population. Hum Reprod. 2009;24:3127–35.PubMedCrossRef Brandes M, van der Steen JO, Bokdam SB, Hamilton CJ, de Bruin JP, Nelen WL, Kremer JA. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population. Hum Reprod. 2009;24:3127–35.PubMedCrossRef
5.
Zurück zum Zitat Dovey S, Sneeringer RM, Penzias AS. Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles. Fertil Steril. 2008;90:2281–6.PubMedCrossRef Dovey S, Sneeringer RM, Penzias AS. Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles. Fertil Steril. 2008;90:2281–6.PubMedCrossRef
6.
Zurück zum Zitat Mulders AG, Laven JS, Eijkemans MJ, Hughes EG, Fauser BC. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update. 2003;9:429–49.PubMedCrossRef Mulders AG, Laven JS, Eijkemans MJ, Hughes EG, Fauser BC. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update. 2003;9:429–49.PubMedCrossRef
7.
Zurück zum Zitat Haebe J, Martin J, Tekepety F, Tummon I, Shepherd K. Success of intrauterine insemination in women aged 40–42 years. Fertil Steril. 2002;78:29–33.PubMedCrossRef Haebe J, Martin J, Tekepety F, Tummon I, Shepherd K. Success of intrauterine insemination in women aged 40–42 years. Fertil Steril. 2002;78:29–33.PubMedCrossRef
8.
Zurück zum Zitat Custers IM, Steures P, van der Steeg JW, van Dessel TJ, Bernardus RE, Bourdrez P, Koks CA, Riedijk WJ, Burggraaff JM, van der Veen F, Mol BW. External validation of a prediction model for an ongoing pregnancy after intrauterine insemination. Fertil Steril. 2007;88:425–31.PubMedCrossRef Custers IM, Steures P, van der Steeg JW, van Dessel TJ, Bernardus RE, Bourdrez P, Koks CA, Riedijk WJ, Burggraaff JM, van der Veen F, Mol BW. External validation of a prediction model for an ongoing pregnancy after intrauterine insemination. Fertil Steril. 2007;88:425–31.PubMedCrossRef
9.
Zurück zum Zitat Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N Engl J Med. 2009;360:236–43.PubMedCrossRef Malizia BA, Hacker MR, Penzias AS. Cumulative live-birth rates after in vitro fertilization. N Engl J Med. 2009;360:236–43.PubMedCrossRef
10.
Zurück zum Zitat Ethics Committee of the American Society for Reproductive Medicine. Fertility treatment when the prognosis is very poor or futile. Fertil Steril. 2009;92:1194–7.CrossRef Ethics Committee of the American Society for Reproductive Medicine. Fertility treatment when the prognosis is very poor or futile. Fertil Steril. 2009;92:1194–7.CrossRef
11.
Zurück zum Zitat Yarali H, Bozdag G, Polat M, Esinler I, Tiras B. Intracytoplasmic sperm injection outcome of women over 39: an analysis of 668 cycles. Arch Gynecol Obstet. 2010;281:349–54.PubMedCrossRef Yarali H, Bozdag G, Polat M, Esinler I, Tiras B. Intracytoplasmic sperm injection outcome of women over 39: an analysis of 668 cycles. Arch Gynecol Obstet. 2010;281:349–54.PubMedCrossRef
12.
Zurück zum Zitat World Health Organization. WHO laboratory manual for the examination of human semen and sperm–cervical mucus interaction. 5th ed. Cambridge: Cambridge University Press; 2010. World Health Organization. WHO laboratory manual for the examination of human semen and sperm–cervical mucus interaction. 5th ed. Cambridge: Cambridge University Press; 2010.
Metadaten
Titel
Alternative strategies to in vitro fertilization/intracytoplasmic sperm injection treatment for aged infertile women
verfasst von
Wataru Isono
Osamu Wada-Hiraike
Akira Shirane
Akihisa Fujimoto
Yutaka Osuga
Tetsu Yano
Yuji Taketani
Publikationsdatum
01.01.2012
Verlag
Springer Japan
Erschienen in
Reproductive Medicine and Biology / Ausgabe 1/2012
Print ISSN: 1445-5781
Elektronische ISSN: 1447-0578
DOI
https://doi.org/10.1007/s12522-011-0107-4

Weitere Artikel der Ausgabe 1/2012

Reproductive Medicine and Biology 1/2012 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.